Determining the clinical stage and treatment of ovarian endometrioma

Abstract

Background: Endometriosis is causing inflammatory infiltration and adhesions in the area, leading to chronic pelvic pain, infertility and disability to work. Aim and Goals: Diagnosing and treating ovarian endometrioma at the clinical stage and making a comparative study of the treatment results. Materials and method: In 2018-2019, 63 women aged (20-45 years) diagnosed with ovarian endometriosis in the gynecology department of the Obstetrics and Gynecology Hospital of the National Center for Maternal and Child Health were included in the study. A hospital-based clinical prospective case-control study was used. Results: First group women received denogest after surgery (during 3 months) pain during menstruation (p<0.001) experienced pain during intercourse (p<0.001), chronic pelvic pain (p<0.016) were reduced. Second group women received denogest before surgery (during 3 months) pain during menstruation (p<0.001) experienced pain during intercourse (p<0.001), chronic pelvic pain (p<0.001) were reduced. A comparative study of during surgery, 14(43.8%) had trouble having the endometrioma removed in first group, 23(74.2%) had no trouble having the endometrioma removed (p<0.02) in second group women. Conclusion: The use of synthetic progestin before surgical removal of moderate to severe endometriosis with laparoscopicy decreases the blood loss during surgery (p<0.02) and facilitate the removal of the endometrium from the ovary.